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Objectives. A mutation in complement factor H (CFH) gene, leading to augmented 
complement activation, is correlated with development of age-related macular degeneration 
(AMD). Therefore, the influence of complement on retinal pigment epithelial (RPE) cells was 
examined concerning their production of proinflammatory and proangiogenic mediators 
relevant in AMD. 
 
Methods. ARPE-19 cells were cultured with human or fetal calf serum (FCS). Therefore, 
complement containing native serum as well as the heat-inactivated form with inoperable 
complement was used. Further, RPE cells were treated with zymosan, a complement 
activating yeast particle. Serum and zymosan in combination was also tested. Levels of 
interleukin (IL)-6, -8 and vascular endothelial growth factor (VEGF) in supernatants were 
examined by ELISA.  
 
Results. Untreated RPE cells produced IL-6, -8 and VEGF constitutively. FCS or human 
serum led to a concentration dependent release of all mediators. Thereby, FCS increased the 
cytokine production stronger than human serum, native serum stronger than heat-inactivated. 
Zymosan only intensified IL-6 and -8 secretion. Combined treatment with serum and zymosan 
resulted in an additive release of IL-8 and VEGF. In contrast, secretion of IL-6 was 
synergistic.  
 
Conclusion. The enhanced expression of IL-6, -8 and VEGF by RPE after exposure to 
complement might explain the correlation between augmented complement production and 
inflammatory processes accompanying AMD. IL-6 production was strongly increased due to 
activation of complement within the serum by zymosan. Thus, complement activation could 
stimulate inflammatory processes by activated RPE cells leading to AMD.   
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